Exicure, Inc., a clinical-stage biotechnology company, develops therapeutics for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. Its drug candidate includes AST-008 that is in a Phase 1b/2 clinical trials in patients with advanced solid tumors.
Market Cap | 10.134 Million | Shares Outstanding | 88.121 Million | Avg 30-day Volume | 9.889 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.1 |
Price to Revenue | 0.0 | Debt to Equity | 0.2697 | EBITDA | -23.237 Million |
Price to Book Value | 2.5095 | Operating Margin | 0.0 | Enterprise Value | 88.859 Million |
Current Ratio | 6.285 | EPS Growth | 0.391 | Quick Ratio | 5.977 |
1 Yr BETA | 1.8798 | 52-week High/Low | 1.98 / 0.1 | Profit Margin | 0.0 |
Operating Cash Flow Growth | -3081.7768 | Altman Z-Score | 0.9436 | Free Cash Flow to Firm | -40.993 Million |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
5,064,703 | 2021-12-21 | 1 | |
GILJOHANN DAVID A CHIEF EXECUTIVE OFFICER |
|
38,666 | 2021-11-15 | 1 |
FELTNER DOUGLAS E. CHIEF MEDICAL OFFICER |
|
15,000 | 2021-11-15 | 1 |
PAPADIMAS ELIAS D. CHIEF ACCOUNTING OFFICER |
|
16,537 | 2021-08-27 | 2 |
|
50,000 | 2021-06-02 | 1 | |
|
50,000 | 2021-06-02 | 1 | |
|
50,000 | 2021-06-02 | 1 | |
|
50,000 | 2021-06-02 | 1 | |
|
50,000 | 2021-06-02 | 1 | |
|
50,000 | 2021-06-02 | 1 | |
|
50,000 | 2021-06-02 | 1 | |
SCHROFF MATTHIAS CHIEF OPERATING OFFICER |
|
7,500 | 2021-05-14 | 0 |
BOCK BRIAN CHIEF FINANCIAL OFFICER |
|
0 | 2021-05-13 | 0 |
|
672,288 | 2020-07-06 | 0 | |
|
11,381,214 | 2020-06-12 | 0 | |
|
11,257,629 | 2020-06-12 | 0 | |
|
0 | 2020-06-04 | 0 | |
|
0 | 2020-06-04 | 0 | |
SNYDER DAVID S CHIEF FINANCIAL OFFICER |
|
248,448 | 2020-03-12 | 0 |
|
0 | 2019-06-14 | 0 | |
|
No longer subject to file | 2017-09-26 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
EXICURE INC XCUR | 2022-05-17 22:15:04 UTC | -27.5483 | 28.3683 | 450000 |
EXICURE INC XCUR | 2022-05-17 21:45:04 UTC | -27.7423 | 28.5623 | 450000 |
EXICURE INC XCUR | 2022-05-17 21:15:03 UTC | -27.7423 | 28.5623 | 450000 |
EXICURE INC XCUR | 2022-05-17 20:45:03 UTC | -28.7254 | 29.5454 | 450000 |
EXICURE INC XCUR | 2022-05-17 20:15:05 UTC | -28.7254 | 29.5454 | 450000 |
EXICURE INC XCUR | 2022-05-17 19:45:04 UTC | -28.7254 | 29.5454 | 450000 |
EXICURE INC XCUR | 2022-05-17 19:15:03 UTC | -28.7254 | 29.5454 | 450000 |
EXICURE INC XCUR | 2022-05-17 18:45:03 UTC | -27.9852 | 28.8052 | 500000 |
EXICURE INC XCUR | 2022-05-17 18:15:03 UTC | -27.9852 | 28.8052 | 550000 |
EXICURE INC XCUR | 2022-05-17 17:45:03 UTC | -27.9852 | 28.8052 | 550000 |
EXICURE INC XCUR | 2022-05-17 17:15:03 UTC | -27.9852 | 28.8052 | 550000 |
EXICURE INC XCUR | 2022-05-17 16:45:04 UTC | -27.9852 | 28.8052 | 600000 |
EXICURE INC XCUR | 2022-05-17 16:15:03 UTC | -27.9852 | 28.8052 | 600000 |
EXICURE INC XCUR | 2022-05-17 15:45:03 UTC | -27.9852 | 28.8052 | 500000 |
EXICURE INC XCUR | 2022-05-17 15:15:03 UTC | -27.9852 | 28.8052 | 500000 |
EXICURE INC XCUR | 2022-05-17 14:45:03 UTC | -39.9201 | 40.7401 | 500000 |
EXICURE INC XCUR | 2022-05-17 14:15:03 UTC | -39.9201 | 40.7401 | 500000 |
EXICURE INC XCUR | 2022-05-17 13:45:03 UTC | -39.9201 | 40.7401 | 500000 |
EXICURE INC XCUR | 2022-05-17 13:15:03 UTC | -39.9201 | 40.7401 | 500000 |
EXICURE INC XCUR | 2022-05-17 12:45:03 UTC | -39.9201 | 40.7401 | 450000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|